Impact Partnership Wealth’s 89bio ETNB Stock Holding History

Impact Partnership Wealth’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-144	Closed	-$2.73K	–	1065
2023 Q2	$2.73K	Buy	+144	New	+$2.53K	﹤0.01%	594

Other funds holding ETNB

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Impact Partnership Wealth's ETNB Position: Q3 2023 in Review

Impact Partnership Wealth sold out of 89bio (ETNB) in Q3 2023, closing a stake of 144 shares — an estimated $2.73K sold.

Impact Partnership Wealth first reported a position in ETNB in Q2 2023 and held it in 1 quarter. The position peaked at $2.73K in Q2 2023. 160 funds tracked by Wall St. Rank hold ETNB as of Q3 2023.

Impact Partnership Wealth reported no remaining 89bio position as of Q3 2023 after selling out during the quarter.
Impact Partnership Wealth sold 144 89bio shares in Q3 2023, an estimated $2.73K.
Impact Partnership Wealth first reported a position in 89bio in Q2 2023 and held it in 1 quarter.
Impact Partnership Wealth's 89bio position peaked at $2.73K in Q2 2023.
160 funds tracked by Wall St. Rank held 89bio as of Q3 2023.

Based on Impact Partnership Wealth's 13F filing for Q3 2023, filed 17 Oct 2023.